Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Brainsight Neuronavigation System

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 1/2 (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05878457Phase 1Completed

Accelerated rTMS for Post-Stroke Apathy

NCT07113067Phase 1/2Recruiting

Accelerated rTMS vs. Sham for Stroke Apathy

Showing all 2 trials

Research Network

Common Treatments

  • Brainsight Neuronavigation System1
  • Magventure Magpro Transcranial Magnetic Stimulation Tms System1
  • Magventure Magpro Transcranial Magnetic Stimulation Tms System Active1
  • Magventure Magpro Transcranial Magnetic Stimulation Tms System Sham1

Active Sponsors

  • Medical University of South Carolina2

Top Investigators

Related Conditions

  • Strokebrain Attack2
  • Stroke Sequelae2
  • Motivation2
  • Apathy2
  • Stroke1

Activity Timeline